115 related articles for article (PubMed ID: 35617527)
21. Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.
Luo L; Zhang H; Nian S; Lv C; Ni B; Wang D; Tian Z
Int J Gynecol Cancer; 2017 Sep; 27(7):1422-1430. PubMed ID: 28604457
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
Pang L; Liang Y; Pan J; Wang JR; Chai YH; Zhao WL
Pediatr Hematol Oncol; 2015 Apr; 32(3):173-81. PubMed ID: 25551271
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of 60 children with anaplastic large cell lymphoma in a single center].
Wang M; Mi Q; Yuan Q; Han YL; Wang JM; Luo CY; Pan C; Tang JY; Gao YJ
Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):824-829. PubMed ID: 34587677
[No Abstract] [Full Text] [Related]
24. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
Cairo MS; Sposto R; Perkins SL; Meadows AT; Hoover-Regan ML; Anderson JR; Siegel SE; Lones MA; Tedeschi-Blok N; Kadin ME; Kjeldsberg CR; Wilson JF; Sanger W; Morris E; Krailo MD; Finlay JL
Br J Haematol; 2003 Feb; 120(4):660-70. PubMed ID: 12588354
[TBL] [Abstract][Full Text] [Related]
25. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
26. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
Li C; Cai S; Wang X; Jiang Z
PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
[TBL] [Abstract][Full Text] [Related]
27. Treatment of pediatric Burkitt lymphoma in Turkey.
Celkan TT; Bariş S; Ozdemir N; Ozkan A; Apak H; Doğru O; Karaman S; Canbolat A; Ozdil M; Aki H; Adaletli I; Kurugoglu S; Hallac M; Yildiz I
J Pediatr Hematol Oncol; 2010 Oct; 32(7):e279-84. PubMed ID: 20736844
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
29. [Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma].
Yang D; Wang P; Chen J; Li CX; Zhang Y; Chen XC; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):645-649. PubMed ID: 30180465
[No Abstract] [Full Text] [Related]
30. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
31. Rare
Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
[TBL] [Abstract][Full Text] [Related]
32. Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience.
Chauhan P; Gupta A; Mandelia A; Yadav S; Rahman K; Nityanand S
Pediatr Hematol Oncol; 2021 May; 38(4):305-318. PubMed ID: 33646922
[TBL] [Abstract][Full Text] [Related]
33. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
[TBL] [Abstract][Full Text] [Related]
34. Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study).
Rahiman EA; Bakhshi S; Deepam Pushpam ; Ramamoorthy J; Das A; Ghara N; Kalra M; Kapoor G; Meena JP; Siddaigarhi S; Thulkar S; Sharma MC; Srinivasan R; Trehan A
Pediatr Hematol Oncol; 2022 Aug; 39(5):391-405. PubMed ID: 34978257
[TBL] [Abstract][Full Text] [Related]
35. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
[TBL] [Abstract][Full Text] [Related]
36. Burkitt lymphoma in children: the Israeli experience.
Eldar AH; Futerman B; Abrahami G; Attias D; Barak AB; Burstein Y; Dvir R; Gabriel H; Horovitz J; Kapelushnik J; Kaplinsky H; Miskin H; Sthoeger D; Toren A; Vilk-Revel S; Weintraub M; Yaniv I; Linn S; Arush MB
J Pediatr Hematol Oncol; 2009 Jun; 31(6):428-36. PubMed ID: 19648792
[TBL] [Abstract][Full Text] [Related]
37. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Fayad L; Thomas D; Romaguera J
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
[TBL] [Abstract][Full Text] [Related]
38. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Ribrag V; Koscielny S; Bosq J; Leguay T; Casasnovas O; Fornecker LM; Recher C; Ghesquieres H; Morschhauser F; Girault S; Le Gouill S; Ojeda-Uribe M; Mariette C; Cornillon J; Cartron G; Verge V; Chassagne-Clément C; Dombret H; Coiffier B; Lamy T; Tilly H; Salles G
Lancet; 2016 Jun; 387(10036):2402-11. PubMed ID: 27080498
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy is an important factor to improve survival in pediatric patients with head and neck rhabdomyosarcoma by enhancing local control: a historical cohort study from a single center.
Wen Y; Huang D; Zhang W; Zhang Y; Hu H; Li J
BMC Pediatr; 2020 May; 20(1):265. PubMed ID: 32471472
[TBL] [Abstract][Full Text] [Related]
40. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
Galicier L; Fieschi C; Borie R; Meignin V; Daniel MT; Gérard L; Oksenhendler E
Blood; 2007 Oct; 110(8):2846-54. PubMed ID: 17609431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
